Loading...
XCSE
AMBUb
Market cap2.90bUSD
Aug 28, Last price  
70.50DKK
Name

Ambu A/S

Chart & performance

D1W1MN
XCSE:AMBUb chart
P/E
30.77
P/S
3.10
EPS
2.29
Div yield, %
0.58%
Shrs. gr., 5y
1.49%
Rev. gr., 5y
11.10%
Revenues
Net income
CFO
Dividend
Dec 04, 20250.41 DKK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
IPO date
Mar 09, 1992
Employees
4,500
Domiciled in
DK
Incorporated in
DK

Valuation

No data to show